Published in Phys Med Biol on July 20, 2010
X-ray-computed tomography contrast agents. Chem Rev (2012) 1.52
Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol Pharm (2013) 1.48
Experimental demonstration of benchtop x-ray fluorescence computed tomography (XFCT) of gold nanoparticle-loaded objects using lead- and tin-filtered polychromatic cone-beams. Phys Med Biol (2012) 1.15
DNA damage enhancement from gold nanoparticles for clinical MV photon beams. Radiat Res (2012) 0.99
Nanoparticles for imaging: top or flop? Radiology (2014) 0.97
Advance of molecular imaging technology and targeted imaging agent in imaging and therapy. Biomed Res Int (2014) 0.94
Multimodality and nanoparticles in medical imaging. Dalton Trans (2011) 0.89
Folic acid-conjugated silica capped gold nanoclusters for targeted fluorescence/X-ray computed tomography imaging. J Nanobiotechnology (2013) 0.86
Ultrasonic imaging of endothelial CD81 expression using CD81-targeted contrast agents in in vitro and in vivo studies. Ultrasound Med Biol (2012) 0.82
A survey of place-exchange reaction for the preparation of water-soluble gold nanoparticles. J Colloid Interface Sci (2012) 0.82
ATP driven clathrin dependent entry of carbon nanospheres prefer cells with glucose receptors. J Nanobiotechnology (2012) 0.78
Nanoscale radiation transport and clinical beam modeling for gold nanoparticle dose enhanced radiotherapy (GNPT) using X-rays. Br J Radiol (2015) 0.78
Second Generation Gold Nanobeacons for Robust K-Edge Imaging with Multi-Energy CT. J Mater Chem (2012) 0.78
Dual-modality, fluorescent, PLGA encapsulated bismuth nanoparticles for molecular and cellular fluorescence imaging and computed tomography. Nanoscale (2014) 0.77
Gold nanoparticles allow detection of early-stage edema in mice via computed tomography imaging. Int J Nanomedicine (2015) 0.75
Depth-resolved analytical model and correction algorithm for photothermal optical coherence tomography. Biomed Opt Express (2016) 0.75
Synthesis of a novel glucose capped gold nanoparticle as a better theranostic candidate. PLoS One (2017) 0.75
Biology of TiO2-oligonucleotide nanocomposites. Nat Mater (2003) 2.68
Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol (2007) 2.44
Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction. Nat Mater (2009) 2.02
The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol Med (Berl) (2009) 1.94
Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys (2005) 1.85
Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J (2012) 1.80
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer (2011) 1.70
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin Cancer Res (2008) 1.68
Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.62
Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res (2010) 1.58
Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys (2008) 1.57
Nanostructured bilayered vanadium oxide electrodes for rechargeable sodium-ion batteries. ACS Nano (2011) 1.52
Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys (2004) 1.52
Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1-expressing myeloma cells. Blood (2011) 1.47
Influence of radioimmunoscintigraphy on postprostatectomy radiotherapy treatment decision making. J Nucl Med (2004) 1.46
MicroRNA expression characterizes oligometastasis(es). PLoS One (2011) 1.45
Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 1.42
Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol (2011) 1.42
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol (2012) 1.41
Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2005) 1.38
2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion. Cancer Chemother Pharmacol (2010) 1.35
Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose. Mol Cancer Ther (2007) 1.22
Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.22
A bioinspired construct that mimics the proton coupled electron transfer between P680*+ and the Tyr(Z)-His190 pair of photosystem II. J Am Chem Soc (2008) 1.19
A high-performance nanobio photocatalyst for targeted brain cancer therapy. Nano Lett (2009) 1.19
Recombination pathways in the Degussa P25 formulation of TiO2: surface versus lattice mechanisms. J Phys Chem B (2005) 1.19
Improved hybrid solar cells via in situ UV polymerization. Small (2009) 1.18
A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol (2009) 1.16
Noninvasive identification of human central sulcus: a comparison of gyral morphology, functional MRI, dipole localization, and direct cortical mapping. Neuroimage (2003) 1.16
Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs. PLoS One (2012) 1.11
Predictors of competing mortality in early breast cancer. Cancer (2010) 1.08
Antiangiogenic activity of 2-deoxy-D-glucose. PLoS One (2010) 1.08
Hollow iron oxide nanoparticles for application in lithium ion batteries. Nano Lett (2012) 1.06
Band gap narrowing of titanium oxide semiconductors by noncompensated anion-cation codoping for enhanced visible-light photoactivity. Phys Rev Lett (2009) 1.03
Feasibility and acute toxicity of hypofractionated radiation in large-breasted patients. Int J Radiat Oncol Biol Phys (2011) 1.03
A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion. Am J Respir Crit Care Med (2010) 1.03
An analysis of radiation necrosis of the central nervous system treated with bevacizumab. J Neurooncol (2014) 1.02
Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells". Cancer Chemother Pharmacol (2006) 1.00
GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells. Cell Cycle (2009) 0.98
Proton transfer at helium temperatures during dioxygen activation by heme monooxygenases. J Am Chem Soc (2004) 0.97
Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists. Am J Clin Oncol (2017) 0.97
Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer (2008) 0.96
Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines. Mol Cancer Ther (2008) 0.96
The wonders of 2-deoxy-D-glucose. IUBMB Life (2014) 0.94
Inhibition of serine palmitoyltransferase delays the onset of radiation-induced pulmonary fibrosis through the negative regulation of sphingosine kinase-1 expression. J Lipid Res (2012) 0.93
Radiation oncology fourth-year medical student clerkships: a targeted needs assessment. Int J Radiat Oncol Biol Phys (2012) 0.93
SERS of semiconducting nanoparticles (TiO(2) hybrid composites). J Am Chem Soc (2009) 0.93
Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev (2003) 0.92
Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer. J Thorac Oncol (2012) 0.91
AuNP-DG: deoxyglucose-labeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging. Mol Imaging Biol (2010) 0.90
Dynamics of localized charges in dopamine-modified TiO(2) and their effect on the formation of reactive oxygen species. J Am Chem Soc (2009) 0.90
Assembly and charge transfer in hybrid TiO(2) architectures using biotin-avidin as a connector. J Am Chem Soc (2005) 0.89
Surface states of titanium dioxide nanoparticles modified with enediol ligands. J Phys Chem B (2006) 0.89
Complex and charge transfer between TiO2 and pyrroloquinoline quinone. J Phys Chem B (2006) 0.89
Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance? Cancer (2005) 0.88
Role of water and carbonates in photocatalytic transformation of CO2 to CH4 on titania. J Am Chem Soc (2011) 0.88
Speciation of L-DOPA on nanorutile as a function of pH and surface coverage using surface-enhanced Raman spectroscopy (SERS). Langmuir (2012) 0.88
In situ visualization of self-assembly of charged gold nanoparticles. J Am Chem Soc (2013) 0.88
Feasibility study for linac-based intensity modulated total marrow irradiation. Med Phys (2008) 0.86
Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression. Antimicrob Agents Chemother (2012) 0.86
Radioimmunoscintigraphy for postprostatectomy radiotherapy: analysis of toxicity and biochemical control. J Nucl Med (2004) 0.85
Hypofractionated radiotherapy does not increase acute toxicity in large-breasted women: results from a prospectively collected series. Am J Clin Oncol (2014) 0.85
Transient inability to distinguish between faces: electrophysiologic studies. J Clin Neurophysiol (2003) 0.85
The important role of tetrahedral Ti4+ sites in the phase transformation and photocatalytic activity of TiO2 nanocomposites. J Am Chem Soc (2008) 0.83
Impact of radioimmunoscintigraphy on definition of clinical target volume for radiotherapy after prostatectomy. J Nucl Med (2004) 0.82
Verification of dose distribution for volumetric modulated arc therapy total marrow irradiation in a humanlike phantom. Med Phys (2012) 0.82
Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells. Cancer Chemother Pharmacol (2013) 0.81
Role of RANK-RANKL-OPG axis in cranial suture homeostasis. J Craniofac Surg (2011) 0.81
Comparison of structural behavior of nanocrystals in randomly packed films and long-range ordered superlattices by time-resolved small angle X-ray scattering. J Am Chem Soc (2009) 0.81
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions. Int J Oncol (2006) 0.81
Characterization of a novel phantom for three-dimensional in vitro cell experiments. Phys Med Biol (2009) 0.81
The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study. Radiat Oncol (2012) 0.81
Enhanced photocatalytic degradation of dye pollutants under visible irradiation on Al(III)-modified TiO2: structure, interaction, and interfacial electron transfer. Environ Sci Technol (2008) 0.80
Bioluminescent imaging of HPV-positive oral tumor growth and its response to image-guided radiotherapy. Cancer Res (2014) 0.79
A prospective study of the utility of magnetic resonance imaging in determining candidacy for partial breast irradiation. Int J Radiat Oncol Biol Phys (2012) 0.79
Targeting cisplatin-resistant human tumor cells with metabolic inhibitors. Cancer Chemother Pharmacol (2013) 0.79
Rationally simplified bistramide analog reversibly targets actin polymerization and inhibits cancer progression in vitro and in vivo. J Am Chem Soc (2010) 0.79
The vanadyl chelate bis(acetylacetonato)oxovanadium(IV) increases the fractional uptake of 2-(fluorine-18)-2-deoxy-D-glucose by cultured human breast carcinoma cells. Dalton Trans (2013) 0.78
Synthesis and characterization of wurtzite ZnTe nanorods with controllable aspect ratios. J Am Chem Soc (2011) 0.78
Facile oxidative conversion of TiH2 to high-concentration Ti(3+)-self-doped rutile TiO2 with visible-light photoactivity. Inorg Chem (2013) 0.78
Algorithm-enabled exploration of image-quality potential of cone-beam CT in image-guided radiation therapy. Phys Med Biol (2015) 0.78
Photoinduced electron transfer pathways in hydrogen-evolving reduced graphene oxide-boosted hybrid nano-bio catalyst. ACS Nano (2014) 0.78
Treatment of brain metastases. Oncology (2014) 0.78
Photoinduced kinetics of SERS in bioinorganic hybrid systems. a case study: dopamine-TiO2. J Phys Chem B (2010) 0.77
Linear accelerator-based intensity-modulated total marrow irradiation technique for treatment of hematologic malignancies: a dosimetric feasibility study. Int J Radiat Oncol Biol Phys (2010) 0.77
A preliminary investigation of local tomography for megavoltage CT imaging. Med Phys (2003) 0.77
Outcomes in black patients with early breast cancer treated with breast conservation therapy. Int J Radiat Oncol Biol Phys (2010) 0.77
Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era. Cancer Med (2015) 0.77
OSP-Immunofluorescent remyelinating oligodendrocytes in the brainstem of toxically-demyelinated Wistar rats. Arq Neuropsiquiatr (2006) 0.77
Small-scale dosimetry: challenges and future directions. Semin Nucl Med (2008) 0.77
Part I-mechanism of adaptation: high nitric oxide adapted A549 cells show enhanced DNA damage response and activation of antiapoptotic pathways. Tumour Biol (2013) 0.76
Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose. Cancer Chemother Pharmacol (2013) 0.76